Results 211 to 220 of about 33,833 (238)
Some of the next articles are maybe not open access.
Jordan Journal of Pharmaceutical Sciences
Background: Bedaquiline, a potent antitubercular drug used in the treatment of multidrug-resistant strains, suffers from low oral bioavailability, a slow onset of therapeutic action, and side effects.
Sayani Bhattacharyya +1 more
semanticscholar +1 more source
Background: Bedaquiline, a potent antitubercular drug used in the treatment of multidrug-resistant strains, suffers from low oral bioavailability, a slow onset of therapeutic action, and side effects.
Sayani Bhattacharyya +1 more
semanticscholar +1 more source
Bedaquiline: An Insight Into its Clinical Use in Multidrug-Resistant Pulmonary Tuberculosis
Drug ResearchEvery year, the World Health Organization reports 500,000 new cases of drug-resistant tuberculosis (TB), which poses a serious global danger. The increased number of XDR-TB and MDR-TB cases reported worldwide necessitates the use of new therapeutic ...
Asad Ahmad +6 more
semanticscholar +1 more source
Exploring the therapeutic and prophylactic potential of bedaquiline in leprosy
International Journal of DermatologyLeprosy remains a significant public health concern despite major strides in treatment and control efforts. The Global Leprosy Strategy 2021–2030 and the National Strategic Plan for Leprosy 2023–2027 majorly focus on facilitating action to reach the goal
Himanshi Khera +9 more
semanticscholar +1 more source